Home   About this service   Get the news  
+32 2 743 34 03

 Belgium  Other Countries
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
UCB [BE0003739530/UCB]   
[22/03/2018]

UCB : UCB Media Room: Cimzia label update in the US

CIMZIA® certolizumab pegol label update marks major advance for women of childbearing age with chronic inflammatory disease in the U.S.U.S. Food and Drug Administration FDA approves label change for UCB’s CIMZIA® certolizumab pegolData added to the label includes firstoftheirkind pharmacokinetic studies demonstrating negligible to low transfer of CIMZIA through placenta and minimal transfer... See more
 
UCB [BE0003739530/UCB]   
[22/02/2018]

UCB : UCB Media Room: Full Year Results

UCB Full Year Report 2017:UCB, with a strong year 2017, is reinforcing a solid foundation for investing in future growthBrussels Belgium, 22 February 2018 – 7:00 CET – regulated information – UCB Full Year Report 2017:Positive growth momentum of core products drive top and bottom line growthProfitability surpasses 30% rEBITDA margin – one year ahead of guidanceR&D update: positive Phase... See more
 
UCB [BE0003739530/UCB]   
[16/02/2018]

UCB : UCB Media Room: American Academy of Dermatology

UCB Advances Psoriasis Pipeline with Positive Data at American Academy of Dermatology Annual Meeting AAD 2018Oral presentation of Phase 2b findings for bimekizumab in the treatment of moderatetosevere chronic plaque psoriasis patients will focus on the effects of dual neutralization of both IL17A and IL17FThree pooled subanalyses from ongoing, Phase 3 studies CIMPASI1, CIMPASI2 and CIMPACT... See more
 
UCB [BE0003739530/UCB]   
[01/02/2018]

UCB : UCB Media Room: Syndesi Therapeutics

UCB and investor syndicate led by Novo Seeds launch Syndesi Therapeutics to develop novel therapeutics for cognitive disordersSyndesi Therapeutics to leverage UCB’s expertise in neurology drug discovery to develop potential therapeutics in cognitive disorders with a firstinclass mechanismSeries A financing of €17 M from a syndicate of Belgian and international investorsBrussels, Belgium –... See more
 
UCB [BE0003739530/UCB]   
[29/01/2018]

UCB : UCB Media Room: Transparency Notification

https://eu=2Evocuspr=2Ecom/Publish/2973226/vcsPRAsset_2973226_60689_a4d= 6fa987e014627bfe9a7773721050a_0=2Ejpg Transparency Notification=C2=A0 Brussels Belgium, 29 January 2018 =E2=80=93 20:00 CET =E2=80=93 reg= ulated information 1=2E Summary of the notification Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of la= rge shareholdings, UCB=C2=A0SA/NV announces... See more